This Is MS Multiple Sclerosis Knowledge & Support Community

This website is probably already known by others here at TIMS but The Society of Interventional Radiology Doctor Finder looks like a good place to begin a local search:

http://members.sirweb.org/index.cfm

Kurt, Are you aware of this UK product? http://www.odstockmedical.com/PatientsSite/ODFSpace.html Looks very similar with raised heel activation except signaling is not wireless? I just started researching and this looks to sell in the U.S. for near 80% less. Without insurance coverage this looks lik...

Scooby, you likely read the same post as I or a post I made passing this info on a couple of days ago. After reading the information I confirmed myself that there is a Rebif PML case in the just released FDA Adverse Event Reporting Database for Q3 2005. I also confirmed the existence of the earlier ...

hmm, but the Teva fear mongering isn't much different than that on this board. :P Bucks, After reading this latest article[AAN Abstract re: PML], I think I would be far more concerned about long term Tysabri use than EDSS differentials! ###### One of the NEJM articles claimed to be coming tonight re...

I can only talk to LDN and I have been on it for 2 years. My two year MRI picture - no new lesions and no active lesions but I still have a lot of symptoms. I just uped my dose from 4. to 4.5 and doing well but remember when I first started LDN vivid dreams, I had not had any dreams that I could rem...

Thanks for posting that Harry. I saw this abstract also on the AAN website. We already know that Tysabri contributed to PML deaths. I don't know what new information this reveals to cause additional concern. Do you? The low counts 6 months after stopping therapy sounds negative but that contrasts wi...

Sifting through all the numbers and using the EDSS numbers in this trial (EDSS being the holy grail of measuring the effectiveness of a MS medication) the difference between Tysabri patients and placebo users was .1, (4.0 - 4.1) hardly what I would call "powerful effectiveness" How are yo...

Came across as a credible objective view until I read this: Relapse rates are not continuous but discrete numbers, and fractional relapse rates are meaningless . Results of the AFFIRM trial indicate that without treatment (and associated risk of side effects) a patient would experience only one extr...